News
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
28 Jan 2026
en
We perform in-house GLP and GcLP sample analysis with optimized methods targeted to your compound needs. To ensure that biomarkers are decision-making for drug development, we deliver not only method and data, but also strategy and data interpretation in collaboration with our clinical research and PKPD modeling teams.
_.webp "A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs")
Subscribe to be the first to get the updates!
